Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure
Clinical trial NCT06786208 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06786208
- Sponsor
- Henan Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-02-01
- Primary completion
- 2025-12-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.